Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Schenkein

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Hospital Practice (Office Ed.)|October 30, 1992
Intravenous IgG for treatment of autoimmune diseaseD P Schenkein
Cancer Treatment and Research|January 19, 1999
Therapy of diffuse aggressive lymphomasY Koc, D P Schenkein
JAMA|July 14, 1993
HematologyK B Miller, D P Schenkein
The Journal of Biological Chemistry|January 10, 1980
Phenylpropynal, a specific, irreversible, non-beta-lactam inhibitor of beta-lactamasesD P Schenkein, R F Pratt
The New England Journal of Medicine|March 27, 1997
Neoplasms and transplantation - trading swords for plowsharesD P Schenkein, R S Schwartz
Seminars in Hematology|July 1, 1992
An assessment of the safety and tolerability of immune globulin intravenous (human) Sandoglobulin prepared in sterile water or 5% dextrose at various concentrationsK B Miller, D P Schenkein, T Fogaren
Clinical Pharmacy|July 1, 1992
Safety and tolerability of an intravenous immune globulin at various concentrations in 5% dextrose injection or sterile water for injectionK B Miller, D P Schenkein, R L Wasserman
The Journal of Biological Chemistry|December 15, 1987
Kinetics and mechanism of inactivation of the RTEM-2 beta-lactamase by phenylpropynal. Identification of the characteristic chromophoreM E Grace, D P Schenkein, R F Pratt
Annals of Internal Medicine|September 1, 1986
Accelerated bone formation causing profound hypocalcemia in acute leukemiaD P Schenkein, W C O'Neill, J Shapiro, et al.
Cancer|March 26, 1999
Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantationY Koc, K B Miller, D P Schenkein, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Hospital Practice (Office Ed.)|October 30, 1992
Intravenous IgG for treatment of autoimmune diseaseD P Schenkein
Cancer Treatment and Research|January 19, 1999
Therapy of diffuse aggressive lymphomasY Koc, D P Schenkein
JAMA|July 14, 1993
HematologyK B Miller, D P Schenkein
The Journal of Biological Chemistry|January 10, 1980
Phenylpropynal, a specific, irreversible, non-beta-lactam inhibitor of beta-lactamasesD P Schenkein, R F Pratt
The New England Journal of Medicine|March 27, 1997
Neoplasms and transplantation - trading swords for plowsharesD P Schenkein, R S Schwartz
Seminars in Hematology|July 1, 1992
An assessment of the safety and tolerability of immune globulin intravenous (human) Sandoglobulin prepared in sterile water or 5% dextrose at various concentrationsK B Miller, D P Schenkein, T Fogaren
Clinical Pharmacy|July 1, 1992
Safety and tolerability of an intravenous immune globulin at various concentrations in 5% dextrose injection or sterile water for injectionK B Miller, D P Schenkein, R L Wasserman
The Journal of Biological Chemistry|December 15, 1987
Kinetics and mechanism of inactivation of the RTEM-2 beta-lactamase by phenylpropynal. Identification of the characteristic chromophoreM E Grace, D P Schenkein, R F Pratt
Annals of Internal Medicine|September 1, 1986
Accelerated bone formation causing profound hypocalcemia in acute leukemiaD P Schenkein, W C O'Neill, J Shapiro, et al.
Cancer|March 26, 1999
Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantationY Koc, K B Miller, D P Schenkein, et al.
Pageof 4